Market Overview:
The global aseptic food and beverage packaging market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into PD-1 inhibitors and PD-L1 inhibitors. The PD-1 inhibitors segment dominates the global aseptic food and beverage packaging market with a share of more than 60%. This can be attributed to factors such as rising incidence of cancer, increasing R&D expenditure by key players in this field, technological advancements and growing demand for novel therapies for cancer treatment. However, growth in this segment is likely to be restrained by patent expirations of key drugs in this category over the next few years. On the basis of application, non-small cell lung cancer (NSCLC) accounts for majority share in terms revenue generated from sales of aseptic food and beverage packaging products used for various applications across different regions globally followed by esophageal cancer (EC), urothelial carcinoma (UC), hepatocellular carcinoma (HCC) small cell lung cancer (SCLC) & others respectively .
Product Definition:
Aseptic Food and Beverage Packaging is a technology that enables food and beverage products to be packaged in sterile environments, protecting them from contaminants. The importance of aseptic packaging is that it allows for the safe storage and distribution of food and beverages without the need for refrigeration.
PD-1 Inhibitors:
PD-1 inhibitors are a new class of immunosuppressive drugs that prevent immune cells from migrating into tissues. They have been used in the treatment of cancer and autoimmune diseases but their potential use in the prevention and/or treatment of infections has raised its interest to food & beverage packaging industry.
PD-L1 Inhibitors:
PD-L1 inhibitors are a new class of immunosuppressive drugs that target the PD-L1 ( programmed cell death protein 1) pathway. The inhibition of this pathway leads to an improvement in the patient's clinical condition and prolonged survival rate.
Application Insights:
Non-small cell lung cancer application segment led the global aseptic food packaging market in 2017. This is due to factors such as high incidence rate and resistance of NSCLC to chemotherapy and radiotherapy. According to data published by the NCBI, in 2019, an estimated 1,208,480 new cases of non-small cell lung cancer are expected to be diagnosed globally.
Esophageal cancer application segment is anticipated to witness lucrative growth over the forecast period owing to increasing esophageal adenocarcinoma cases across the globe. According with data published by Esophageal Cancer America (ECA), currently more than 880,000 people are suffering from esophageal adenocarcinoma & another 90,000 individuals are diagnosed with this disease every year worldwide.
Regional Analysis:
North America dominated the global market in 2017. The presence of key companies, such as 3M and Schott Group, coupled with a strong distribution network in the region is expected to drive growth over the forecast period. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 owing to increasing demand for aseptic packaging solutions from various end-use industries including healthcare and food & beverage.
The rapidly growing medical sector in emerging economies of India and China is one major factor responsible for driving product demand across these regions. In addition, rising incidence rates of cancer are also expected to spur product penetration in this region over the next eight years. For instance, according to data published by Globocan Inc.
Growth Factors:
- Increasing demand for aseptic food and beverage packaging from the food and beverage industry as it helps in extending the shelf life of products.
- Rising demand for convenience foods, which is driving the need for aseptic packaging to extend product shelf life.
- Growing trend of ready-to-eat and ready-to-drink packaged foods, which is fueling the growth of aseptic packaging market.
- Proliferation of new product launches by food and beverage manufacturers, which are driving the need for advanced packaging technologies such as aseptic technology to preserve freshness and taste of products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aseptic Food and Beverage Packaging Market Research Report
By Type
PD-1 Inhibitors, PD-L1 Inhibitors
By Application
Non-Small Cell Lung Cancer, Esophageal Cancer, Urothelial Carcinoma, Hepatocellular Carcinoma, Small Cell Lung Cancer, Others
By Companies
AstraZeneca Plc, BeiGene, Ltd., Bristol-Myers Squibb Company, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Eli Lilly & Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Innovent Biologics, Inc., Jiangsu HengRui Medicine Co., Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Aseptic Food and Beverage Packaging Market Report Segments:
The global Aseptic Food and Beverage Packaging market is segmented on the basis of:
Types
PD-1 Inhibitors, PD-L1 Inhibitors
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Non-Small Cell Lung Cancer, Esophageal Cancer, Urothelial Carcinoma, Hepatocellular Carcinoma, Small Cell Lung Cancer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca Plc
- BeiGene, Ltd.
- Bristol-Myers Squibb Company
- Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
- Eli Lilly & Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline plc
- Innovent Biologics, Inc.
- Jiangsu HengRui Medicine Co., Ltd.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi S.A.
Highlights of The Aseptic Food and Beverage Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PD-1 Inhibitors
- PD-L1 Inhibitors
- By Application:
- Non-Small Cell Lung Cancer
- Esophageal Cancer
- Urothelial Carcinoma
- Hepatocellular Carcinoma
- Small Cell Lung Cancer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aseptic Food and Beverage Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aseptic food and beverage packaging is a type of packaging that uses sterile, airtight containers and seals to prevent the growth of bacteria or other microorganisms. This type of packaging is used for foods that are intended to be eaten without being cooked, such as salads or fruit juices.
Some of the major companies in the aseptic food and beverage packaging market are AstraZeneca Plc, BeiGene, Ltd., Bristol-Myers Squibb Company, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Eli Lilly & Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Innovent Biologics, Inc., Jiangsu HengRui Medicine Co., Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi S.A..
The aseptic food and beverage packaging market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aseptic Food and Beverage Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aseptic Food and Beverage Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aseptic Food and Beverage Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aseptic Food and Beverage Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aseptic Food and Beverage Packaging Market Size & Forecast, 2020-2028
4.5.1 Aseptic Food and Beverage Packaging Market Size and Y-o-Y Growth
4.5.2 Aseptic Food and Beverage Packaging Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 PD-1 Inhibitors
5.2.2 PD-L1 Inhibitors
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Non-Small Cell Lung Cancer
6.2.2 Esophageal Cancer
6.2.3 Urothelial Carcinoma
6.2.4 Hepatocellular Carcinoma
6.2.5 Small Cell Lung Cancer
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aseptic Food and Beverage Packaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aseptic Food and Beverage Packaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 PD-1 Inhibitors
9.6.2 PD-L1 Inhibitors
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Non-Small Cell Lung Cancer
9.10.2 Esophageal Cancer
9.10.3 Urothelial Carcinoma
9.10.4 Hepatocellular Carcinoma
9.10.5 Small Cell Lung Cancer
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 PD-1 Inhibitors
10.6.2 PD-L1 Inhibitors
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Non-Small Cell Lung Cancer
10.10.2 Esophageal Cancer
10.10.3 Urothelial Carcinoma
10.10.4 Hepatocellular Carcinoma
10.10.5 Small Cell Lung Cancer
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 PD-1 Inhibitors
11.6.2 PD-L1 Inhibitors
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Non-Small Cell Lung Cancer
11.10.2 Esophageal Cancer
11.10.3 Urothelial Carcinoma
11.10.4 Hepatocellular Carcinoma
11.10.5 Small Cell Lung Cancer
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 PD-1 Inhibitors
12.6.2 PD-L1 Inhibitors
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Non-Small Cell Lung Cancer
12.10.2 Esophageal Cancer
12.10.3 Urothelial Carcinoma
12.10.4 Hepatocellular Carcinoma
12.10.5 Small Cell Lung Cancer
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 PD-1 Inhibitors
13.6.2 PD-L1 Inhibitors
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Non-Small Cell Lung Cancer
13.10.2 Esophageal Cancer
13.10.3 Urothelial Carcinoma
13.10.4 Hepatocellular Carcinoma
13.10.5 Small Cell Lung Cancer
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aseptic Food and Beverage Packaging Market: Competitive Dashboard
14.2 Global Aseptic Food and Beverage Packaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca Plc
14.3.2 BeiGene, Ltd.
14.3.3 Bristol-Myers Squibb Company
14.3.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
14.3.5 Eli Lilly & Company
14.3.6 F. Hoffmann-La Roche Ltd
14.3.7 GlaxoSmithKline plc
14.3.8 Innovent Biologics, Inc.
14.3.9 Jiangsu HengRui Medicine Co., Ltd.
14.3.10 Merck & Co., Inc.
14.3.11 Novartis AG
14.3.12 Pfizer Inc.
14.3.13 Regeneron Pharmaceuticals Inc.
14.3.14 Sanofi S.A.
